Analysis of NTRK expression in gastric and esophageal adenocarcinoma (AGE) with pan-TRK immunohistochemistry.

导出原文传递

翻译打印收藏纠错

第一作者： A,Arnold

第一单位： Institute of Pathology, Charité - Universitätsmedizin Berlin, Germany. Electronic address: alexander.arnold@charite.de.

作者： A,Arnold ^[1] ; S,Daum ^[2] ; M,von Winterfeld ^[3] ; E,Berg ^[4] ; M,Hummel ^[4] ; D,Horst ^[4] ; B,Rau ^[5] ; U,Stein ^[6] ; C,Treese ^[2]

作者单位： Institute of Pathology, Charité - Universitätsmedizin Berlin, Germany. Electronic address: alexander.arnold@charite.de. ^[1] Department of Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité - Universitätsmedizin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany. ^[2] Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. ^[3] Institute of Pathology, Charité - Universitätsmedizin Berlin, Germany. ^[4] Department of Surgery, Campus Virchow-Klinikum and Campus Mitte, Charité - Universitätsmedizin, Berlin, Germany. ^[5] Experimental and Clinical Research Center, Charité - Universitätsmedizin and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. ^[6]

关键词 Gastric and esophageal adenocarcinoma (AGE)Larotrectinib Neurotrophic-tropomyosin receptor tyrosine kinase (NTRK) gene fusion